Driehaus Capital Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Driehaus Capital Management’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-73,078	Closed	-$667K	–	630
2015 Q4	$667K	Buy	+73,078	New	+$563K	0.02%	424
2014 Q3	–	Sell	-70,515	Closed	-$1.08M	–	608
2014 Q2	$1.08M	Sell	70,515 -79,762	-53%	-$1.15M	0.03%	429
2014 Q1	$2.72M	Sell	150,277 -8,221	-5%	-$158K	0.09%	282
2013 Q4	$2.2M	Sell	158,498 -15,308	-9%	-$176K	0.08%	296
2013 Q3	$1.82M	Buy	173,806 +59,945	+53%	+$595K	0.07%	292
2013 Q2	$889K	Buy	+113,861	New	+$993K	0.04%	353

Other funds holding SGMO

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Driehaus Capital Management's SGMO Position: Q1 2016 in Review

Driehaus Capital Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2016, closing a stake of 73,078 shares — an estimated $667K sold.

Driehaus Capital Management first reported a position in SGMO in Q2 2013 and held it in 6 quarters. The position peaked at $2.72M in Q1 2014. 143 funds tracked by Wall St. Rank hold SGMO as of Q1 2016.

Driehaus Capital Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2016 after selling out during the quarter.
Driehaus Capital Management sold 73,078 SANGAMO THERAPEUTICS INC shares in Q1 2016, an estimated $667K.
Driehaus Capital Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 6 quarters.
Driehaus Capital Management's SANGAMO THERAPEUTICS INC position peaked at $2.72M in Q1 2014.
143 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2016.

Based on Driehaus Capital Management's 13F filing for Q1 2016, filed 13 May 2016.